Dr. Cutter is Professor of Biostatistics in the UAB School of Public Health in the Department of Biostatistics. Dr. Cutter has a major interest in design, analysis and interpretation of clinical trials, epidemiologic studies and evaluation research. He is currently directing the coordinating centers of multiple NIH randomized trials: the Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex and the randomized Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis (PREVeNT trial) both NINDS funded studies. He is the Deputy Director of the Operations Center and Director of the Coordinating Center for Neurofibromatosis Consortium with 7 current ongoing trials. He directs the coordinating center for the NHLBI Chronic Hypertension in Pregnancy (CHAP) and is the director of the Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE) clinical trial funded by NHLBI. He is the PI of the recently completed Trial of Thymectomy plus Prednisone versus Prednisone alone in the treatment of non-thymomatous Myasthenia Gravis (MGTx). He is the immediate past Director of the NARCOMS multiple sclerosis patient registry and current Director the Myasthenia Gravis patient registry. He is the Director, Biostatistics/Bioinformatics Resource (BBR) Core in the O’brien Center for Acute Kidney Injury Research, UAB-USC (NIDDK), UAB (NIAID) and Associate Director, National Center for High Impact Clinical Trials in Rehabilitation Medicine. He is the current President of the Consortium of MS Centers.
He is a member of numerous data and safety monitoring committees for the NIH, Pharmaceutical Companies and foundations as well as advisory committees. He serves on the International Clinical Trials Committee of the National MS Society and International MS Societies as well as being on the editorial board of the journal MS and writes a column Statistics for the Neurologist in Practice for Neurology for clinical practice as a contributing editor. He is an Associate Editor of Alzheimer’s Disease Translational Research. He is a member of the Statistics Editorial Board for the Journal of the American Society of Nephrology (JASN). He is a mentor on numerous K awards from across campus, PhD and master’s students and teaches in various national and international short courses.